ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in New Haven, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Rhinitis
Dust Mite Allergy
Lung Diseases
Chronic Obstructive Pulmonary Disease
Respiratory Tract Diseases

Asthma trials near New Haven, CT, USA:

REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study

study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...

Active, not recruiting
Asthma
Other: Spirometry
Drug: Mepolizumab

Phase 4

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

New Haven, Connecticut, United States and 65 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Hawthorne, New York, United States and 335 other locations

Locations recently updated

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...

Enrolling
Asthma
Biological: Tezepelumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Hawthorne, New York, United States and 142 other locations

This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...

Active, not recruiting
Asthma
Drug: GSK5784283
Drug: Placebo

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

New Haven, Connecticut, United States and 133 other locations

treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...

Enrolling
Asthma
Wheezing
Drug: Placebo
Drug: Dupilumab

Phase 3

Sanofi
Sanofi

Hawthorne, New York, United States and 74 other locations

This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condi...

Active, not recruiting
Asthma
Drug: dupilumab
Drug: Matching Placebo

Phase 4

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Hawthorne, New York, United States of America and 77 other locations

inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...

Active, not recruiting
Asthma
Drug: TEV-56248
Drug: Albuterol sulfate

Phase 3

Teva Branded Pharmaceutical Products R&D LLC

Hawthorne, New York, United States and 394 other locations

MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis...

Enrolling
Asthma
Combination Product: BDA MDI
Combination Product: AS MDI

Phase 3

AstraZeneca
AstraZeneca

Hawthorne, New York, United States and 137 other locations

adults (do not have disease) and or in adults with mild-to-moderate asthma. This is the first time the study medicine is being given to peop...

Not yet enrolling
Asthma
Healthy Adults
Drug: Midazolam
Drug: Placebo

Phase 1

Pfizer
Pfizer

New Haven, Connecticut, United States

The objectives of this clinical trial are to evaluate the safety and tolerability of topically applied ATR12-351, to understand what the body does to...

Enrolling
Netherton Syndrome
Drug: ATR12-351

Phase 1

Azitra

New Haven, Connecticut, United States and 1 other location

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems